William Jl Rieflin, Director at RAPT Therapeutics, Inc. (RAPT), bought 51,390 shares at $12.00 ($96K) on 2019-11-04, disclosed to the SEC on 2019-11-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 43,390 | $0 | 0.0% |
| 2 | $12.00 | 8,000 | $96K | 100.0% |
| Total | $1.87 avg | 51,390 | $96K | 100% |
| Filing → |
| XNPT | BUY | 2011-12-16 | $39K | — | Filing → |
| XNPT | BUY | 2011-11-22 | $44K | — | Filing → |
| XNPT | BUY | 2011-11-09 | $27K | — | Filing → |